Cargando…

BACE1 Inhibitors for Alzheimer’s Disease: The Past, Present and Any Future?

Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder and the most common cause of dementia in the elderly. The complexity of AD has hindered the development of either a cure or a disease-modifying therapy to halt the disease progression. Numerous hypotheses were presented in ord...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bazzari, Firas H., Bazzari, Amjad H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785888/ https://www.ncbi.nlm.nih.gov/pubmed/36557955 http://dx.doi.org/10.3390/molecules27248823

Ejemplares similares

Assessing Stigma towards Mental Illness in Relation to Demographics Attitudes and Past Experiences among Pharmacy Students in a Jordanian University Sample
por: Bazzari, Amjad H., et al.
Publicado: (2023)

BDNF Therapeutic Mechanisms in Neuropsychiatric Disorders
por: Bazzari, Amjad H., et al.
Publicado: (2022)

Attitudes and Knowledge Regarding the Therapeutic Use of Cannabinoids among Community Pharmacists: A Pilot Cross-Sectional Study in Amman, Jordan
por: Bazzari, Firas H., et al.
Publicado: (2023)

Neuromodulators and Long-Term Synaptic Plasticity in Learning and Memory: A Steered-Glutamatergic Perspective
por: Bazzari, Amjad H., et al.
Publicado: (2019)

Chenodeoxycholic Acid Ameliorates AlCl(3)-Induced Alzheimer’s Disease Neurotoxicity and Cognitive Deterioration via Enhanced Insulin Signaling in Rats
por: Bazzari, Firas H., et al.
Publicado: (2019)

BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
por: Vassar, Robert
Publicado: (2014)

Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment
por: Coimbra, Judite R. M., et al.
Publicado: (2018)

Stepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs
por: Yan, Riqiang
Publicado: (2016)

Repurposing food molecules as a potential BACE1 inhibitor for Alzheimer’s disease
por: Mukerjee, Nobendu, et al.
Publicado: (2022)

The past, present, and future of disease-modifying therapies for Alzheimer’s disease
por: SUZUKI, Kazushi, et al.
Publicado: (2017)

The Alzheimer's disease β-secretase enzyme, BACE1
por: Cole, Sarah L, et al.
Publicado: (2007)

The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease
por: Neumann, Ulf, et al.
Publicado: (2018)

Role of BACE1 in Alzheimer’s synaptic function
por: Das, Brati, et al.
Publicado: (2017)

Immunotherapy for Alzheimer’s disease: past, present and future
por: Spencer, Brian, et al.
Publicado: (2014)

Verapamil and Alzheimer’s Disease: Past, Present, and Future
por: Popović, Natalija, et al.
Publicado: (2020)

BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer’s Disease
por: Maia, Miguel A., et al.
Publicado: (2019)

Post-Translational Modifications of BACE1 in Alzheimer's Disease
por: Wen, Wen, et al.
Publicado: (2022)

BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer’s Disease Markers in Elderly Healthy Participants
por: Timmers, Maarten, et al.
Publicado: (2017)

In Silico Design of BACE1 Inhibitor for Alzheimer's Disease by Traditional Chinese Medicine
por: Huang, Hung-Jin, et al.
Publicado: (2014)

Advances in Deep Neuropathological Phenotyping of Alzheimer Disease: Past, Present, and Future
por: Shakir, Mustafa N, et al.
Publicado: (2022)

The Past and the Future of Alzheimer’s Disease Fluid Biomarkers(1)
por: Blennow, Kaj, et al.
Publicado: (2018)

Current status on Alzheimer disease molecular genetics: from past, to present, to future
por: Bettens, Karolien, et al.
Publicado: (2010)

Application of Marine Natural Products against Alzheimer’s Disease: Past, Present and Future
por: Hu, Di, et al.
Publicado: (2023)

Development and Structural Modification of BACE1 Inhibitors
por: Gu, Ting, et al.
Publicado: (2016)

BACE2: A Promising Neuroprotective Candidate for Alzheimer’s Disease
por: Yeap, Yee Jie, et al.
Publicado: (2023)

Steroid Sulphatase and Its Inhibitors: Past, Present, and Future
por: Foster, Paul A.
Publicado: (2021)

From BACE1 Inhibitor to Multifunctionality of Tryptoline and Tryptamine Triazole Derivatives for Alzheimer’s Disease
por: Jiaranaikulwanitch, Jutamas, et al.
Publicado: (2012)

The β-secretase enzyme BACE1 as a therapeutic target for Alzheimer's disease
por: Vassar, Robert, et al.
Publicado: (2011)

BACE1 Translation: At the Crossroads Between Alzheimer’s Disease Neurodegeneration and Memory Consolidation
por: Guix, Francesc X., et al.
Publicado: (2019)

Is It the Twilight of BACE1 Inhibitors?
por: Hrabinova, Martina, et al.
Publicado: (2021)

Preclinical Models for Alzheimer’s Disease: Past, Present, and Future Approaches
por: Akhtar, Ansab, et al.
Publicado: (2022)

Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson’s Disease: Past, Present, and Future
por: Tan, Yu-Yan, et al.
Publicado: (2022)

BACE1 Function and Inhibition: Implications of Intervention in the Amyloid Pathway of Alzheimer’s Disease Pathology
por: Koelsch, Gerald
Publicado: (2017)

BACE1: A Key Regulator in Alzheimer’s Disease Progression and Current Development of its Inhibitors
por: Patel, Smith, et al.
Publicado: (2022)

A promising, novel, and unique BACE1 inhibitor emerges in the quest to prevent Alzheimer's disease
por: Dobrowolska Zakaria, Justyna A, et al.
Publicado: (2018)

BACE1, the Alzheimer's beta-secretase enzyme, in health and disease
por: Vassar, Robert
Publicado: (2012)

BACE1, the Alzheimer’s beta-secretase enzyme, in health and disease
por: Vassar, Robert
Publicado: (2013)

BACE1 inhibition as a therapeutic strategy for Alzheimer's disease
por: Vassar, Robert
Publicado: (2016)

BACE1: from biomarker to Alzheimer’s disease therapeutical target
por: Cervellati, Carlo, et al.
Publicado: (2021)

PS1 Affects the Pathology of Alzheimer’s Disease by Regulating BACE1 Distribution in the ER and BACE1 Maturation in the Golgi Apparatus
por: Li, Nuomin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ta6sfn84mqm3m2urs9pv5n5amq